Abstract
Nogalamycin (NOG) is a member of the anthracycline glycoside natural products; no total syntheses have yet been reported and there is minimal understanding of how the aglycone substitution pattern and the identities of the A- and D-ring sugar impact anticancer activity and toxicity. This paper reports progress towards a modular approach to NOG that could enable systematic structure-activity relationship studies. Key steps include a regioselective benzyne cycloaddition and a reductive ring-opening to assemble a versatile AB core for analogue synthesis.
Supplementary materials
Title
Supplementary experimental and characterization
Description
The SI contains experimental procedures and tabulated characterization data for all new compounds.
Actions
Title
NMR Spectra
Description
Proton and carbon NMR spectra are provided for all new isolable compounds.
Actions